Dr David G. Poplack
#124,466
Most Influential Person Now
Dr David G. Poplack's AcademicInfluence.com Rankings
Dr David G. Poplackmedical Degrees
Medical
#1965
World Rank
#2353
Historical Rank
Oncology
#104
World Rank
#108
Historical Rank
Download Badge
Medical
Why Is Dr David G. Poplack Influential?
(Suggest an Edit or Addition)Dr David G. Poplack's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Principles and Practice of Pediatric Oncology (1989) (2581)
- Expression of a multidrug-resistance gene in human tumors and tissues. (1987) (1529)
- Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. (1983) (596)
- Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. (1981) (567)
- Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. (1980) (420)
- Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. (1989) (365)
- Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? (1983) (259)
- Abnormal CT Scans of the Brain in Asymptomatic Children with Acute Lymphocytic Leukemia after Prophylactic Treatment of the Central Nervous System with Radiation and Intrathecal Chemotherapy (1978) (257)
- Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. (1987) (234)
- Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. (1979) (225)
- Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. (1996) (219)
- The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. (1981) (192)
- Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. (1984) (184)
- Inhibition of first‐pass metabolism in cancer chemotherapy: Interaction of 6‐mercaptopurine and allopurinol (1983) (162)
- Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. (1988) (161)
- Pregnancy outcome following cancer chemotherapy. (1980) (161)
- Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. (1986) (158)
- L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. (1981) (156)
- Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. (1978) (152)
- Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities. (1985) (151)
- Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapse (1978) (146)
- Central nervous system pharmacology of antileukemic drugs. (1989) (144)
- Dideoxyinosine in children with symptomatic human immunodeficiency virus infection (1991) (142)
- "Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. (1978) (140)
- Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. (1989) (132)
- Impact of nutrition on pharmacokinetics of anti‐neoplastic agents (1998) (130)
- Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. (1978) (129)
- Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia. (1987) (111)
- Memory and Learning Sequelae in Long‐term Survivors of Acute Lymphoblastic Leukemia: Association with Attention Deficits (1990) (110)
- Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. (1976) (104)
- Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. (1992) (103)
- Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. (1993) (101)
- Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. (1993) (100)
- Remission induction of meningeal leukemia with high-dose intravenous methotrexate. (1985) (100)
- Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoir. (1979) (98)
- Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. (1985) (97)
- Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. (1998) (97)
- Neurotoxicities of current leukemia therapy. (1979) (96)
- Biochemical Markers in Lymphoid Malignancy (1980) (92)
- Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood. (1990) (92)
- Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. (1981) (90)
- Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics. (1982) (90)
- Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. (1981) (89)
- Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. (2003) (87)
- Pharmacokinetics of subcutaneous methotrexate. (1988) (86)
- A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid. (1990) (84)
- IMMUNODEFICIENCY IN FAMILIAL ERYTHROPHAGOCYTIC LYMPHOHISTIOCYTOSIS (1978) (83)
- The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. (1987) (80)
- Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. (1986) (78)
- Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. (1995) (78)
- Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL). (1984) (78)
- Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. (1980) (76)
- Acute lymphoblastic leukemia in childhood. (1985) (75)
- Human T-cell antigen receptor (TCR) delta-chain locus and elements responsible for its deletion are within the TCR alpha-chain locus. (1988) (71)
- Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. (1993) (70)
- Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. (1996) (66)
- Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. (1998) (66)
- Abnormal computed tomography brain scans in children with acute lymphoblastic leukemia: serial long-term follow-up. (1985) (66)
- Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion. (1994) (65)
- Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoam. (1993) (65)
- ADRENAL SUPPRESSION AFTER SHORT-TERM CORTICOSTEROID THERAPY (1979) (64)
- Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies (1989) (64)
- The ommaya reservoir. Newly recognized complications and recommendations for insertion and use (1978) (64)
- T cell receptor alpha-, beta-, and gamma-genes in T cell and pre-B cell acute lymphoblastic leukemia. (1987) (61)
- Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. (1997) (61)
- Childhood cancer survivor care: development of the Passport for Care (2014) (59)
- A phase II evaluation of thiotepa in pediatric central nervous system malignancies (1993) (58)
- Variability in the oral bioavailability of all-trans-retinoic acid. (1993) (58)
- Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid. (1988) (54)
- Phase I/pharmacokinetic reevaluation of thioTEPA. (1991) (54)
- Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. (2005) (54)
- Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. (2004) (53)
- A primate model for study of methotrexate pharmacokinetics in the central nervous system. (1977) (52)
- The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. (1994) (52)
- Acute megakaryoblastic leukemia in childhood (1984) (50)
- Blindness during remission in two patients with acute lymphoblastic leukemia. A possible complication of multimodality therapy (1977) (49)
- A Review of 37 Patients with Burkitt's Lymphoma (1980) (49)
- Primate model for long-term study of intraventricularly or intrathecally administered drugs and intracranial pressure. (1977) (48)
- Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey. (1984) (48)
- Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia. (1985) (47)
- Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2. (1991) (47)
- Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. (1986) (47)
- Methotrexate levels in the interstitial space and seminiferous tubule of rat testis. (1982) (46)
- Passport for care: implementing the survivorship care plan. (2009) (46)
- Lipid Peroxidation in the Killing of Phagocytized Pneumococci (1974) (45)
- Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. (1979) (44)
- Active transport of methotrexate from cerebrospinal fluid in humans. (1980) (44)
- Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients. (1990) (44)
- Plasma and cerebrospinal fluid pharmacokinetics of recombinant interferon alpha A in monkeys: comparison of intravenous, intramuscular, and intraventricular delivery. (1985) (43)
- Central nervous system leukemia. (1996) (42)
- Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration. (1995) (41)
- Hypothalamic-pituitary dysfunction following CNS prophylaxis in acute lymphocytic leukemia: correlation with CT scan abnormalities. (1979) (40)
- Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. (1991) (40)
- Activation of leukemic pro-suppressor cells to become suppressor-effector cells. Influence of cooperating normal T cells. (1981) (39)
- Transient acute hepatotoxicity of high-dose methotrexate therapy during childhood. (1987) (39)
- Very high-dose methotrexate (33.6 g/m2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P (2006) (39)
- Leukoencephalopathy following chemotherapy for rhabdomyosarcoma: reversibility of cerebral changes demonstrated by computed tomography. (1977) (39)
- Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys. (1992) (37)
- Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys. (1988) (37)
- Dose-dependent pharmacokinetics of all-trans-retinoic acid. (1992) (36)
- A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. (1995) (35)
- A Phase I and II Trial of Dose‐Intensified Cyclophosphamide and GM‐CSF in Pediatric Malignant Brain Tumors (1995) (34)
- Adverse sequelae of central nervous system therapy (1985) (34)
- Pharmacology of Antineoplastic Agents in Cerebrospinal Fluid (1980) (33)
- Intrathecal administration of topotecan in nonhuman primates (2004) (32)
- ACUTE ENCEPHALOPATHY AFTER INITIATION OF CRANIAL IRRADIATION FOR MENINGEAL LEUKÆMIA (1978) (32)
- Leadership: “They Never Taught Me This in Medical School” (2010) (32)
- Ability of a new antitumor agent, AZQ, to penetrate into cerebrospinal fluid. (1981) (32)
- Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies. (1989) (32)
- Active clearance of corticotropin-releasing factor from the cerebrospinal fluid. (1985) (32)
- Infectious complications of intraventricular reservoirs in cancer patients (1987) (31)
- Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia. (1986) (31)
- Pharmacologic approaches to the treatment of meningeal malignancy. (1991) (31)
- Characterization of acute lymphoblastic leukemia of childhood by immunoglobulin and T-cell receptor gene patterns. (1991) (31)
- Altered central nervous system pharmacology of methotrexate in childhood leukemia: another sign of meningeal relapse. (1985) (31)
- Purine pathway enzyme abnormalities in acute lymphoblastic leukemia. (1981) (30)
- Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines. (1985) (30)
- Stability of 5-fluorouracil in whole blood and plasma. (1987) (29)
- New cytotoxic drugs for intrathecal administration (1998) (29)
- Ascending myelopathy after chemotherapy for central nervous system acute lymphoblastic leukemia: correlation with cerebrospinal fluid myelin basic protein. (1985) (29)
- Acute Nonlymphoblastic Leukemia (1989) (28)
- Pharmacokinetics of trimetrexate (NSC 352122) in monkeys. (1986) (28)
- Combined modality treatment of Burkitt's lymphoma. (1978) (28)
- A Phase I Study of Interleukin‐2 in Children with Cancer (1992) (28)
- Human T-cell antigen receptor (TCR) 6-chain locus and elements responsible for its deletion are within the TCR a-chain locus (28)
- Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. (1992) (28)
- Lactate dehydrogenase isoenzymes in normal and malignant human lymphoid cells. (1982) (27)
- Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates. (1980) (27)
- Pharmacokinetics of PEG-l-asparaginase and plasma and cerebrospinal fluidl-asparagine concentrations in the rhesus monkey (2004) (27)
- Prolonged granulocytopenia from incompatible platelet transfusions. (1974) (27)
- Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys. (1987) (26)
- Intraventricular concentration times time (C × T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma (1999) (26)
- Chronic ventricular cerebrospinal fluid sampling, drug injections, and pressure monitoring using subcutaneous reservoirs in monkeys. (1977) (25)
- Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone. (1984) (25)
- Cerebrospinal fluid and plasma pharmacokinetics of morphine infusions in pediatrie cancer patients and rhesus monkeys (1987) (25)
- Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia. (1981) (25)
- Candida arthritis treated with amphotericin B. (1975) (24)
- Folate and methotrexate polyglutamate tissue levels in rhesus monkeys following chronic low-dose methotrexate. (1987) (24)
- Phase I trial and pharmacokinetic evaluation of fazarabine in children. (1989) (24)
- Chronic myelomonocytic leukemia in childhood (1981) (24)
- Lymphoblast purine pathway enzymes in B-cell acute lymphoblastic leukemia. (1981) (23)
- Methotrexate-induced oral mucositis and salivary methotrexate concentrations (2004) (23)
- Management strategies in acute lymphoblastic leukemia. (2011) (22)
- Bacillus Calmette-Guérin enhancement of colony-stimulating activity and myeloid colony formation following administration of cyclophosphamide. (1979) (22)
- Chronopharmacokinetics of oral methotrexate and 6-mercaptopurine: is there diurnal variation in the disposition of antileukemic therapy? (1989) (22)
- Experimental approaches to the treatment of CNS leukemia. (1979) (22)
- Transplantation of leukemic bone marrow treated with cytotoxic antileukemic antibodies and complement. (1982) (22)
- Pharmacokinetics of pyrazoloacridine in the rhesus monkey. (1991) (22)
- Massive intrathecal overdose: "check the label twice!". (1984) (21)
- Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule. (1990) (20)
- Principles and Practice of Pediatric Oncology (7th ed.) (2015) (20)
- Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fluid. (1985) (20)
- Reversible dementia temporally associated with intraventricular therapy with methotrexate in a child with acute myelogenous leukemia. (1976) (20)
- Identification of 6-mercaptopurine riboside in patients receiving 6-mercaptopurine as a prolonged intravenous infusion. (1984) (19)
- Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II) (2004) (19)
- Acute lymphoblastic leukemia in childhood. (1985) (19)
- Phase II evaluation of topotecan for pediatric central nervous system tumors. (1996) (19)
- An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016 (2018) (18)
- A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. (1997) (18)
- Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia. (1991) (18)
- Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates. (1990) (18)
- Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model. (1999) (18)
- Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeys (1995) (17)
- Altered phenytoin clearance during intensive chemotherapy for acute lymphoblastic leukemia. (1988) (17)
- The effect of Mycobacterium bovis (Bacillus Calmette-Guérin) on macrophage random migration, chemotaxis, and pinocytosis. (1976) (16)
- The mononuclear phagocyte system: role in expression of immunocompetence in neonatal and adult life. (1979) (16)
- High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids. (1990) (16)
- Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T‐cell lymphoma (1982) (16)
- Phase II study of 5‐azacytidine in sarcomas of bone (1982) (15)
- Improving Childhood Cancer Survivor Care Through Web-Based Platforms. (2018) (15)
- ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity. (1979) (15)
- A Primate Model (2006) (15)
- Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys. (1982) (15)
- Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers. (1998) (15)
- Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies. (1983) (15)
- Inhibition of human lymphoproliferation by intravenous lipid emulsion. (1982) (14)
- Adverse prognostic influence of hepatitis b virus infection in acute lymphoblastic leukemia (1986) (14)
- Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts. (1993) (14)
- Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys. (1985) (14)
- Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. (1978) (14)
- The Role of Pharmacology in Pediatric Oncology (1987) (14)
- Acceleration of myeloid recovery from cyclophosphamide-induced leukopenia by pretreatment with Bacillus Calmette-Guérin. (1978) (14)
- Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome (1988) (13)
- Increasing diversity in pediatric hematology/oncology (2011) (13)
- IMMUNODEFICIENCY IN FAMILIAL ERYTHROPHAGOCYTIC LYMPHOHISTIOCYTOSIS (1978) (12)
- Pharmacokinetics of subcutaneous azidothymidine in rhesus monkeys (1989) (12)
- Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis. (1977) (12)
- Pharmacologic strategies for the treatment of meningeal malignancy (2004) (12)
- Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. (1985) (12)
- Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine. (1992) (12)
- Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma. (1995) (12)
- Central nervous system leukemia : prevention and treatment (1983) (11)
- Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates (1990) (11)
- A Phase I Study of Interleukin-2 in Children with Cancer (1992) (11)
- Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor. (1993) (10)
- Characterization of cross-resistance to methotrexate in a human breast cancer cell line selected for resistance to melphalan. (1995) (10)
- Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine. (1986) (10)
- Stimulation of the beta-subunit of the IL-2 receptor induces MHC-unrestricted cytotoxicity in T acute lymphoblastic leukemia cells and normal thymocytes. (1988) (10)
- Leukemic relapse 5 1/2 years after allogeneic bone marrow transplantation. (1978) (9)
- Preclinical pharmacology of arabinosyl-5-azacytidine in nonhuman primates. (1988) (9)
- A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors (2008) (9)
- Fc receptors on human T lymphocytes. V: Effects of colchicine and cytochalasin B on Fc receptor expression. (1980) (9)
- Retinoblastoma treatment [2] (1999) (9)
- 2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition. (1999) (9)
- Pharmacokinetics of mercaptopurine in children with acute lymphocytic leukemia. (1990) (9)
- Late soft tissue recurrence of acute lymphoblastic leukemia in a site of antecedent trauma. (1978) (9)
- Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells. (1993) (9)
- Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine. (1982) (8)
- Delayed allergic reactions following intramuscular L-asparaginase. (1980) (8)
- Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin. (1982) (8)
- Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma. (1978) (7)
- Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen. (1981) (7)
- Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutations. (1994) (7)
- Evaluation of Adverse Sequelae of Central Nervous System Prophylaxis in Acute Lymphoblastic Leukemia (1983) (7)
- A pediatric phase I and pharmacokinetic study of spirohydantoin mustard. (1988) (7)
- Bacteriological isolation garment. (1974) (7)
- Capacity building: a novel pediatric hematology-oncology fellowship program in sub-Saharan Africa. (2018) (7)
- Involvement of chromosome No. 22 in neuroblastoma (1980) (7)
- Relationship of 5'-nucleotidase activity and antileukemic effect in 2'-deoxycoformycin therapy. (1982) (7)
- Characteristics of long-term survivors in AML. (1978) (6)
- Current concepts. Biochemical markers in lymphoid malignancy. (1980) (6)
- A CRITIQUE OF TECHNIQUES OF MACROPHAGE-MONOCYTE DEPLETION IN STUDIES OF HUMAN PERIPHERAL BLOOD MONONUCLEAR LEUKOCYTE (MNL) FUNCTION (1977) (6)
- Detection of double minute chromosomes in a child with acute lymphoblastic leukemia. (1998) (6)
- Misonidazole blood and cerebrospinal fluid kinetics in monkeys following intravenous and intrathecal administration. (1981) (6)
- Report from the International Society of Endocrinology (1985) (6)
- An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys (2004) (5)
- Advances in the treatment of meningeal cancers. (1995) (5)
- Intravenous infusion of zidovudine (AZT) in children with HIV infection. (1989) (5)
- Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys. (1982) (5)
- Cerebrospinal fluid and plasma pharmacokinetics of morphine infusions in pediatric cancer patients and rhesus monkeys. (1987) (4)
- Complications of leukemia. (1991) (4)
- Pharmacokinetics of ICRF-187 in the cerebrospinal fluid of subhuman primates. (1980) (4)
- Intracranial and otological presentation of acute lymphocytic leukemia. (1985) (4)
- Enhancement of Delivery of Antineoplastic Drugs into Cerebrospinal Fluid (1983) (4)
- Pharmacologic approaches to the treatment of central nervous system malignancy (1987) (4)
- Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate (1993) (4)
- A Primate Model for the Study of CNS Pharmacokinetics Antineoplastic Agents (1979) (4)
- Meningeal relapse of orbital rhabdomyosarcoma. (1978) (4)
- The child with recurrent solid tumor. (1991) (3)
- High-performance liquid chromatographic method for the analysis of 2',3'-dideoxycytidine in human plasma. (1990) (3)
- Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity (1984) (3)
- Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor. (1993) (3)
- The effect of amitriptyline on the central nervous system penetration of methotrexate. (1986) (3)
- Pharmacology and drug resistance in childhood lymphoblastic leukemia. (1990) (3)
- Hepatitis B virus infection in the Wiskott-Aldrich syndrome. (1976) (3)
- A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study (1995) (3)
- A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia (2004) (3)
- Late CNS sequelae in long term survivors of childhood leukemia. (1988) (3)
- Introduction: pediatric oncology. (2005) (3)
- Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas (1990) (3)
- Pharmacokinetics of 6-mercaptopurine (6MP) in the monkey. I. Disposition from plasma and cerebrospinal fluid following iv bolus. (1983) (3)
- Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the Rhesus monkey (1993) (2)
- 26 – Molecular Genetics of Acute Lymphoblastic Leukemia (2015) (2)
- The influence of route of administration on the hepatic uptake of methotrexate. (1986) (2)
- Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. (1988) (2)
- Successful transplantation in mice of leukemic bone marrow incubated with cytotoxic anti-leukemic antibodies. Abstr. (1981) (1)
- Principles and Practice of Pediatric Oncology, 7e (2016) (1)
- RELAPSE DOSE CHEMOTHERAPY OF BURKITT'S LYMPHOMA IN (1978) (1)
- HumanT-cell antigen receptor (TCR)6-chain locus andelements responsible foritsdeletion arewithin theTCRa-chain locus (1988) (1)
- New methods of administering old drugs: IV infusion of mercaptopurine (1987) (1)
- Pharmacokinetics of Commonly used Anti-Leukemic agents in Children (1991) (1)
- Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells. (1984) (1)
- Effect of sex-steroids on the survival of akr mice. Abstr. (1982) (1)
- Development of chemotherapy treatment for pediatric brain tumors. (1991) (1)
- Intrathecal 5-fluorouracil in the rhesus monkey (2004) (1)
- Offering HOPE to Pediatric Oncology Patients Around the Globe (2017) (1)
- The effect of BCG pretreatment on myeloid recovery from cyclophosphamide (CY) induced leukopenia (1977) (1)
- Phase I/Pharmacokinetic Réévaluation of ThioTEPA1 (1991) (1)
- Methotrexate CNS Pharmacokinetics in Combination Chemotherapy (1979) (1)
- Multidisciplinary Subspecialty Capacity Building for Global Pediatric Oncology (2020) (1)
- Clonal expansion of germline B-lineage acute lymphoblastic leukemia in severe combined immunodeficient mice. (1995) (1)
- Pharmacokinetics of Intra ventricular and Intravenous A^A^A^'-Triethylenethiophosphoramide (Thiotepa) in Rhesus Monkeys and Humans (2006) (0)
- 92. Capacity-limited metabolism of all-trans-retinoic add and the time course of enzyme induction of the non-human primate (1992) (0)
- Identification of p53 gene abnormalities in acute lymphoblastic leukemia of childhood (1991) (0)
- Clinician perceptions of Passport for Care, a web‐based clinical decision support tool for survivorship care plan delivery (2022) (0)
- DNA Rearrangements as Unique Markers of Clonal Evolution, Recurrence and Translocation (1986) (0)
- 385 ABNORMALITIES IN GROWTH HORMONE SECRETION AFTER CRANIAL IRRADIATION IN PRIMATES (1981) (0)
- The detection of Fc-IgA receptors on T and non-T, non-B acute leukemic lymphoblasts. (1980) (0)
- Cerebrospinal Fluid Markers of Central Nervous System Radiation and Chemotherapy Damage (1983) (0)
- Abstract 98: Custom Gene Fusion Assays for the Rapid Diagnosis of Pediatric Cancers in Low-Resourced Settings (2021) (0)
- Phase I C linical T rial o f I ntrathecal T opotecan i n P atients With N eoplastic M eningitis (2003) (0)
- Web tool helps tailor follow-up care of childhood cancer survivors (2012) (0)
- A phase I study of taxotere in children with refractory cancer (1995) (0)
- Perspective on...the new PSA screening recommendations. (2011) (0)
- Furine Pathway Enzyme Abnormalities in Acute Lymphoblastic Leukemia1 (2006) (0)
- Chapter 27 – Molecular Genetics of ALL (2008) (0)
- A rapid, single step technique for determination of B and T cell surface markers in malignant lymphoid cells. (1982) (0)
- 2 *-b-FLUORO-2 * , 3 *-DIDEOXYADENOSINE , LODENOSINE , IN RHESUS MONKEYS : PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS AND URINARY DISPOSITION 1 (1999) (0)
- Treatment of Meningeal Leukemia: Investigation of New Approaches with Conventional Agents (1983) (0)
- Complications of Leukemia (1991) (0)
- The Effect of Mycobacteriumbovis(BacillusCalmetteGuërin) on Macrophage RandomMigration,Chemotaxis,and Pinocytosis1 (1976) (0)
- Pediatrie Phase I Trial and Pharmacokinetic Study of Topotecan Administered as a 24-Hour Continuous Infusion 1 (2006) (0)
- Ara-ctp formation and retention in s180 cells in the presence of adriamycin (adr). Abstr. (1981) (0)
- Radiation (and Medical) Biosurveillance (2008) (0)
- Inhibition of Fc-IgG receptor (Fc-IgGR) expression and Fc-IgGR-mediated function of monocytes (MΦ) by purine nucleosides (1982) (0)
- Pharmacokinetics and Metabolism of CyclopentenylCytosine in Nonhuman Primates (1990) (0)
- What Is the Optimal Therapy for Childhood AML (2002) (0)
- 169. Phase I and pharmacokinetic evaluation of all-trans retinoic acid in pediatric patients and pharmacokinetic evaluation in the nonhuman primate (1992) (0)
- Very high dose cyclophosphamide with imidazole carboximide and vineristine sulf ate in the treatment of Stasre IV neuroblastoma (1985) (0)
- STUDIES OF MONOCYTE Fc RECEPTOR AVIDITY AND MONOCYTE MEDIATED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (MMADCC) IN MAN (1977) (0)
- Abstract 1021: Custom gene fusion assay for the rapid diagnosis of pediatric cancer in Sub-Saharan Africa (2022) (0)
- Modulation of thiopurine cytotoxicity by physiological concentrations of hypoxanthine (1986) (0)
- [Infectious complications from intraventricular route of administration in cancer patients]. (1990) (0)
- Clinician perceptions of passport for care for survivorship care plan delivery. (2022) (0)
- IMMUNODEFICIENCY IN LYMPHOHISTIOCYTOSIS: DEFECTIVE CELLULAR IMMUNITY IN ASSOCIATION WITH HYPERLIPIDEMIA (1977) (0)
- Evidence of normal testicular function in boys following chemotherapy for acute lymphoblastic leukemia (1981) (0)
- High Preponderance of High-Risk Phenotypes of Acute Leukemias Among Ugandan Children (2022) (0)
- Intrathecally administered m-AMSA in the rhesus monkey. (1984) (0)
- in Normal and Malignant Human Lymphoid Cells (2017) (0)
- Postintrathecal Methotrexate Encephalopathy (1977) (0)
- MOLECULAR GENETIC CLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) OF CHILDHOOD AND INFANCY: 11 (1989) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Dr David G. Poplack?
Dr David G. Poplack is affiliated with the following schools:
